Equities
North America
Europe
Asia
Oceania
Middle East
South America
Africa
»
More Equities
Indexes
America
DOW JONES
NASDAQ COMP
S&P 500
NASDAQ 100
TSX COMP
MEXICO IPC
BOVESPA
Index and indicators
VOLATILITY
DOLLAR INDEX
»
More Indexes
Europe
FTSE 100
DAX
CAC 40
BEL 20
ATHEX COMP
RUSLAND RTS
SMI
IBEX 35
MILANO MIB
AEX
PSI 20
POLAND WIG
Asia, Pacific
NIKKEI 225
SHANGHAI COMP
HANG SENG
KOSPI COMP
SENSEX
TAIWAN TWSE
THAILAND 50
SYDNEY ASX
Middle East
EGX 30
TELAVIV 25
Commodities
Energy
Crude Oil (WTI)
Crude Oil (BRENT)
URANIUM
Index and indicators
CRB COMMODITY
BALTIC DRY
»
More Commodities
Metals
GOLD
SILVER
PLATINUM
PALLADIUM
ALUMINIUM
COPPER
LEAD
TIN
ZINC
Agriculture
COFFEE
SUGAR
CORN
COCOA
COTTOM
WHEAT
PALM IOL
SOYBEANS
Currencies
EUR / USD
USD / JPY
GBP / USD
AUD / USD
USD / CHF
USD / CAD
»
More Currencies
News
Latest News
Markets
Commodities
Business Leaders
Most Popular News
Hot News
Finance Calendar
Economic Calendar
Companies
All News
Press Releases
Events
Corporate actions
Economy & Forex
All News
Currencies / Forex
Economic Events
Press releases
Analysis
All Analysis
Commentaries
Stock Trading Strategies
Index Analysis
Forex Analysis
Commodity Analysis
Top & Flop
Gainers & Losers
Unusual Volumes
STIM
Top / Flop RSI
Top / Flop Gaps
Top / Flop Capitalizations
Market Screener
Technical Analysis
Oversold stocks
Overbought stocks
Close to resistances
Close to supports
Accumulation phase
Most volatile stocks
Fundamentals
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Market Screener
Sectors
Finance Calendar
Calendar
Finance Calendar
Economic Calendar
4-Traders Homepage
>
Shares
>
Nyse
>
AbbVie Inc
ABBV
US00287Y1091
ABBVIE INC
(ABBV)
7
Real-time BATS US -
05/23 04:59:59 pm
46.66
USD
-0.21%
4d ago
ABBVIE INC
: AbbVie Initiates Phase 3 Study of Its Investigational Compound..
7d ago
ABBVIE INC
: AbbVie and Galapagos Extend GLPG0634 Collaboration to Include ..
05/15
ABBVIE INC
: AbbVie to Present Data on Investigational Anti-Cancer Compound..
Summary
Quotes
Chart Analysis
News
Calendar
Company
Financials
Consensus
Revisions
Forum
Upcoming events on ABBVIE INC
- No events available -
Past events on ABBVIE INC
05/14/13 | 01:40pm
Bank of America Merrill Lynch Health Care Conference
04/26/13 | 09:00am
Q1 2013 Earnings Call
04/26/13
Q1 2013 Earnings Release
04/11/13
ex-dividend day
Annual publications
Previous year
Next Year
Annual results
2012
2013 (e)
2014 (e)
Sales
Million $
Released
Forecast
Spread
18 380
18 033
1,9%
18 427
18 873
Operating income
(EBITDA)
Million $
Released
Forecast
Spread
6 967
7 238
-3,7%
7 414
7 559
Operating profit
(EBIT)
Million $
Released
Forecast
Spread
5 817
6 455
-9,9%
7 049
7 261
Pre-Tax Profit
(EBT)
Million $
Released
Forecast
Spread
5 725
5 104
12%
6 726
Net income
Million $
Released
Forecast
Spread
5 275
4 937
6,8%
4 455
5 058
EPS
$
Released
Forecast
Spread
3,35
3,33
0,53%
2,83
3,26
Announcement Date
01/23/2013
Quarterly / Semiannualy publications
Previous year
Previous period
Next period
Next Year
Quarterly results
Q4
2012
Q1
2013
Q2
2013 (e)
Q3
2013 (e)
Sales
Million $
Released
Forecast
Spread
4 830
4 329
4 301
0,65%
4 534
4 432
Operating income
(EBITDA)
Million $
Released
Forecast
Spread
2 035
1 565
1 689
-7,4%
1 861
1 848
Operating profit
(EBIT)
Million $
Released
Forecast
Spread
1 842
1 473
1 465
0,57%
1 691
1 661
Pre-Tax Profit
(EBT)
Released
Forecast
Spread
Net income
Million $
Released
Forecast
Spread
1 267
EPS
$
Released
Forecast
Spread
1,00
Announcement Date
04/26/2013
© 2013 Thomson Reuters
© 2013 Factset
Advertisement
Loading...
Dynamic quotes
ON
|
OFF
My Watchlist
|
My Portfolio
Copyright © 2013 Surperformance. All rights reserved.